In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 1035-1040

  Appleman, Maria D ^a   Belzberg, Howard ^a   Citron, Diane M ^a   Heseltine, Peter N R ^a   Yellin, Albert E ^a   Murray, James ^a   Berne, Thomas V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFEPIME; DOXYCYCLINE; MEROPENEM; NETILMICIN; RIFAMPICIN; SULBACTAM; TROVAFLOXACIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; DRUG POTENTIATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; ANTI-BACTERIAL AGENTS; BURNS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; INTENSIVE CARE UNITS; KINETICS; MICROBIAL SENSITIVITY TESTS;

EID: 0034061105     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.1035-1040.2000     Document Type: Article

References (15)

1. Barry, A. L., and C. Thornberry. 1980. Susceptibility testing: diffusion test procedures, p. 463-474. In E. H. Lennette, A. Balows, and J. P. Truant (ed.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.
2. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
3. Cisneros, J. M., M. J. Reyes, J. Pachon, B. Becerril, F. J. Caballero, J. L. Garcia-Garmendia, C. Ortiz, and A. R. Cobacho. 1996. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis. 22:1026-1032.
4. Corbella, X., M. Pujor, J. Ayats, M. Sendra, C. Ardanuy, M. A. Dominguez, J. Linares, J. Ariza, and F. Gudiol. 1996. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin. Infect. Dis. 23:329-334.
5. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-444. In V. Loria (ed.), Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, Md.
6. Go, E. S., C. Urban, J. Burns, B. Kreiswirth, W. Eisner, N. Mariano, K. M. Osinka-Snipas, and J. J. Rahal. 1994. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 344:1329-1332.
7. Graevenitz, A. V. 1995. Acinetobacter. Alcaligenes, Moraxella, and other nonfermentative gram-negative bacteria, p. 520-522. In F. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology. American Society for Microbiology, Washington, D.C.
8. Horrevorts, A., K. Bergman, L. Kollee, I. Breuker, I. Tjernberg, and L. Dijkshoorn. 1995. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J. Clin. Microbiol. 33:1567-1572.
9. Joly-Gillou, M. L., D. Decre, J. L. Herrman, E. Bourdelier, and E. Bergogne-Berezin. 1995. Bactericidal in-vitro activity of β-lactams and β-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. J. Antimicrob. Chemother. 36:619-629.
10. Kuah, B. G., G. Kumarasinghe, J. Darrein, and H. R. Chang. 1994. Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore. Antimicrob. Agents Chemother. 38:2502-2503.
11. Lortholary, O., J. Y. Fagon, A. B. Hoi, M. A. Slama, J. Pierre, P. Giral, R. Rosenzweig, L. Gutmann, M. Safar, and J. Acar. 1995. Nosocomial acquisition of Acinetobacter baumannii: risk factors and prognosis. Clin. Infect. Dis. 20:790-796.
12. National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial susceptibility testing, seventh informational supplement. M100-S7, vol. 17, no. 2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Neu, H. C. 1991. Clinical microbiology of azithromycin. Am. J. Med. 91(3A): 12S-18S.
14. Schentag, J. J., and C. H. Ballow. 1991. Tissue-directed pharmacokinetics. Am. J. Med. 91(3A):5S-11S.
15. Traub, W. H., and M. Spohr. 1989. Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3 and genospecies 6). Antimicrob. Agents Chemother. 33:1617-1619.